Prevention of hepatitis B virus recurrence after living donor liver transplantation

Transplantation Proceedings

Volumn 36, Issue 9, 2004, Pages 2764-2767

  Ali, H ^a,b   Egawa, H ^a   Uryuhara, K ^a   Ogawa, K ^a   Kasahara, M ^a   Ueda, M ^a   Marusawa, H ^a   Nabeshima, M ^a   Tanaka, K ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Cairo Egypt   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TRANSPLANTATION; MALE; ORGAN DONOR; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; VIRUS MUTATION;

ANTIVIRAL AGENTS; DNA, VIRAL; HEPATITIS B; HUMANS; LAMIVUDINE; LIVER TRANSPLANTATION; LIVING DONORS; PREOPERATIVE CARE; RECURRENCE; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD;

EID: 11144261801     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.10.035     Document Type: Article

References (22)

1. N.A. Terrault Hepatitis B virus and liver transplantation Clin Liver Dis 3 1999 398
2. S. Todo, A. Demetris, Thiel Van Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease Hepatology 13 1991 619
3. V. Mazzaferro, E. Regalia, F. Montalto Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis Liver 16 1996 117
4. D. Samuel, R. Muller, G. Alexander Liver transplantation in European patients with the hepatitis B surface antigen N Engl J Med 329 1993 1842
5. M.G. Ghany, B. Ayola, F.G. Villamil Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite of hepatitis B immunoglobulin prophylaxis Hepatology 27 1998 213
6. U. Protzer-Knolle, U. Naumann, R. Bartenschlager Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation Hepatology 27 1998 254
7. H.P. Lemmens, J.M. Langrehr, G. Blumhardt Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis Transplant Proc 26 1994 3622
8. J.M. Langrehr, H.P. Lemmens, H. Keck Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis Transplant Proc 27 1995 1215
9. G.L. Grazi, A. Maziotti, C. Sama Liver transplantation in HBsAg-positive HBV-DNA-negative cirrhotics: immunoprophylaxis and long-term outcome Liver Transplant Surg 2 1996 418
10. N.A. Terrault, S. Zhou, C. Combs Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin Hepatology 24 1996 1327
11. R.P. Perillo, T. Wright, J. Rakela A multicenter United States-Canadian Trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B Hepatology 33 2001 424
12. R.A. De Man, Ai Bartholomeusz, H.G. Niesters The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss J Hepatol 29 1998 669
13. H.L. Tillmann, C. Trautwein, T. Bock Mutational pattern of hepatitis B virus on sequentional therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation Hepatology 30 1999 244
14. N. Singh, T. Gayowski, C.F. Wannsteldt Pretransplant Famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation Transplantation 63 1997 1415
15. D. Seehofer, N. Rayes, U. Naumann Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation Transplantation 72 2001 1381
16. J. Rosenau, J.B. Matthias, H.L. Tillmann Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation--possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection J Hepatol 34 2001 895
17. K. Kamisango, C. Kamogawa, M. Sumi Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay J Clin Microbiol 37 1999 310
18. T. Santantonio, S. Gunther, M. Sterneck Liver graft infection by HBV S-gene mutants in transplant patients receiving long-term HBIg prophylaxis Hepatogastroenterology 46 1999 1848
19. L. Grellier, D. Multimer, M. Ahmed Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis Lancet 1 1996 1212
20. D. Multimer, D. Pillay, E. Dragon High pre-treatment serum hepatitis B virus titer predicts failure of Lamivudine prophylaxis and graft reinfection after liver transplantation J Hepatol 30 1999 715
21. B. Rehermann, C. Ferrari, C. Pasquinelli The hepatitis B virus persists for decades after patients recovery from acute viral hepatitis despite active maintenance of a cytotoxic T lymphocyte response Nat Med 2 1996 1104
22. J.S. Markowitz, P. Martin, A.J. Conrad Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin Hepatology 28 1998 585